Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes
暂无分享,去创建一个
Martijn G. Steffens | J. Schalken | P. Mulders | I. V. van Oort | Rianne J. Hendriks | Siebren Dijkstra | Sander A. Jannink | Inge M. van Oort | Peter F.A. Mulders | Jack A. Schalken | S. Dijkstra | M. Steffens | R. Hendriks
[1] L. Kiemeney,et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. , 2002, Cancer research.
[2] J. Schalken,et al. High‐resolution ERG‐expression profiling on GeneChip exon 1.0 ST arrays in primary and castration‐resistant prostate cancer , 2013, BJU international.
[3] T. D. de Reijke,et al. Prostate cancer biomarker profiles in urinary sediments and exosomes. , 2014, The Journal of urology.
[4] Johan Skog,et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. , 2010, Kidney International.
[5] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[6] M. Rubin,et al. TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion , 2006, The American journal of surgical pathology.
[7] J Alfred Witjes,et al. The Time-Resolved Fluorescence-Based PCA3 Test on Urinary Sediments after Digital Rectal Examination; a Dutch Multicenter Validation of the Diagnostic Performance , 2007, Clinical Cancer Research.
[8] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[9] R. Setterquist,et al. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery. , 2015, Methods.
[10] J. Ward,et al. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study. , 2013, The Journal of urology.
[11] S. Bentink,et al. A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result , 2015, Prostate Cancer and Prostatic Disease.
[12] J. Witjes,et al. Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate Cancer , 2007, Clinical Cancer Research.
[13] W. Ellis,et al. A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[14] Jianjun Yu,et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. , 2008, Cancer research.
[15] S. Varambally,et al. Antibody-based detection of ERG rearrangement-positive prostate cancer. , 2010, Neoplasia.
[16] M. Truong,et al. Toward the detection of prostate cancer in urine: a critical analysis. , 2013, The Journal of urology.
[17] Angela Mariotto,et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. , 2009, Journal of the National Cancer Institute.
[18] J Alfred Witjes,et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. , 2003, European urology.
[19] J. Krijgsveld,et al. Exosomal Secretion of Cytoplasmic Prostate Cancer Xenograft-derived Proteins* , 2009, Molecular & Cellular Proteomics.
[20] Joanne L Welton,et al. Can urinary exosomes act as treatment response markers in prostate cancer? , 2009, Journal of Translational Medicine.
[21] W. Isaacs,et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. , 1999, Cancer research.
[22] J. Dear,et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. , 2006, Kidney international.
[23] J. Schalken,et al. Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion. , 2012, The Journal of urology.
[24] T. D. de Reijke,et al. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. , 2014, European urology.
[25] Amy Blase,et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. , 2007, Urology.
[26] L. Marks,et al. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. , 2006, Clinical chemistry.
[27] X. Breakefield,et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer , 2009, British Journal of Cancer.
[28] L. Kiemeney,et al. DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer , 2003 .
[29] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[30] J. Schalken,et al. Urinary biomarkers for prostate cancer: a review. , 2013, Asian journal of andrology.
[31] G. Kristiansen,et al. ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies , 2012, Prostate Cancer and Prostatic Diseases.